New Born Solutions
Barcelona-based medtech (Kriba) that builds AI-powered high-resolution ultrasound systems (Neosonics®) for non-invasive screening of infections in serous fluids across neonates, peritoneal dialysis patients, and ophthalmology patients.
- Company typePrivate
- Founded2015
- HeadquartersBarcelona, Spain
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What New Born Solutions does
New Born Solutions, operating commercially as Kriba, is a Barcelona-based private medical device company founded in 2015 that develops non-invasive screening systems for infections in serous body fluids. Its core product is the Neosonics® platform, which combines proprietary high-resolution ultrasound imaging with deep learning algorithms to enable rapid, non-invasive screening in place of invasive diagnostic procedures such as lumbar puncture. The platform is applied across three clinical verticals: transfontanellar ultrasound-based meningitis screening in neonates and young infants, automated peritonitis detection and monitoring in home peritoneal dialysis patients, and deep learning-aided anterior uveitis screening in ophthalmology.
The technology stack is centered on in-house deep learning models trained on multicentre ultrasound datasets collected in Spain, Morocco, and Mozambique, with validation published in Pediatric Research (2025), Ultrasound Med Biol (2025), Sensors (2024), and the Journal of the American Society of Nephrology (2024). The company has been supported by European Innovation Council (EIC) Accelerator grant funding spanning three years, an earlier EISMEA grant (2018), and operates with a lean team of 1-10 employees.
The business model is enterprise field sales targeting healthcare institutions: neonatal intensive care units and pediatric hospitals, peritoneal dialysis centers and nephrology departments, and ophthalmology clinics. Go-to-market relies on scientific credibility built through peer-reviewed publications, conference presentations at ASN Kidney Week, MICCAI, ESPID, ASTMH, and AEP, and a registered Neosonics® trademark. Pricing is not publicly disclosed and commercial inquiries are handled via a single email channel. Revenue streams referenced include medical device and technology licensing and EIC grant funding; no commercial sales revenue is currently disclosed.
New Born Solutions firmographics
Firmographics- Name
- New Born Solutions
- Legal name
- Kriba
- Website
- https://newborn.solutions
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Barcelona-based medtech (Kriba) that builds AI-powered high-resolution ultrasound systems (Neosonics®) for non-invasive screening of infections in serous fluids across neonates, peritoneal dialysis patients, and ophthalmology patients.
- Ownership category
- akta.pro rank
New Born Solutions industry classification
Industry- Product category
- Medical Imaging Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Ultrasound & Echography Systems (HLAHABAD)
- akta.pro secondary industries
- Medical Imaging AI (HDAAAEAH), Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ), AI Orchestration & Imaging Analytics Platforms (Model Management/Triage) (HLACALAG)
Keywords
Where New Born Solutions is headquartered
LocationHeadquarters
- HQ city
- Barcelona
- HQ country
- Spain
- HQ region
- Europe
Offices1 record
Markets served
New Born Solutions business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations
Revenue model
- Medical Device and Technology Licensing: Revenue generated from proprietary medical devices and AI-powered screening technology, including potential licensing of the Neosonics® system for clinical use in healthcare settings
- European Innovation Council Accelerator Funding: Grant funding received from EIC Accelerator program supporting three years of development and commercialization efforts
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
New Born Solutions product offering
Product offeringCore offering
New Born Solutions (operating as Kriba) develops Neosonics, a proprietary medical device platform that combines high-resolution ultrasound imaging with artificial intelligence and deep learning to enable non-invasive screening, diagnosis, and monitoring of infections in serous body fluids. The platform addresses three clinical applications: transfontanellar ultrasound-based meningitis screening for newborns and young infants, automated peritonitis detection and monitoring for patients on home peritoneal dialysis, and deep learning-aided uveitis screening for ophthalmology patients.
Product overview
New Born Solutions (operating as Kriba) offers Neosonics, a unified non-invasive medical screening platform that combines high-resolution ultrasound imaging with artificial intelligence for screening, diagnosis, and monitoring of infections in serous body fluids. The platform encompasses three distinct clinical applications: meningitis screening for newborns and young infants via transfontanellar ultrasound, peritonitis detection and monitoring for kidney patients on peritoneal dialysis, and uveitis screening for ophthalmology patients. All three applications share the core AI-powered ultrasound analysis technology but target different anatomical areas and clinical conditions.
Differentiator
Problem solved
Functional benefit
Brands
- Neosonics®: Registered trademark for non-invasive screening technology
Products and services
- Neosonics Platform A proprietary non-invasive medical device platform combining high-resolution ultrasound imaging with AI and deep learning algorithms for screening, diagnosis, and monitoring of infections in serous body fluids. Targeted at healthcare institutions including neonatal ICUs, peritoneal dialysis centers, and ophthalmology clinics. Registered under the Neosonics® trademark.
- Neosonics Meningitis Screening (Newborn Care) Non-invasive transfontanellar ultrasound-based screening system for detecting meningitis in newborns and young infants, using AI-powered image analysis. Designed for neonatal intensive care units and pediatric hospitals to replace invasive lumbar puncture procedures.
- Neosonics Peritonitis Detection (Kidney Care) AI-driven system for automatic non-invasive detection and monitoring of peritonitis in patients on home peritoneal dialysis, using high-resolution ultrasonography. Targeted at peritoneal dialysis centers and nephrology departments for continuous infection surveillance.
- Neosonics Uveitis Screening (Eye Care) Deep learning-aided screening system for anterior uveitis detection using high-resolution ultrasound imaging. Targeted at ophthalmology clinics and eye care centers for detecting cellularity in the anterior chamber and screening for ocular inflammation.
Quantifiable outcome
- Published clinical validation in Pediatric Research (2025) for non-invasive meningitis screening in neonates and infants
- +1 more outcomes
Companies that use New Born Solutions
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
New Born Solutions technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature4 records
New Born Solutions partnerships and signals
Strategic signalScale indicators4 records
Recent moves6 records
Expansion highlights6 records
New Born Solutions competitors and assessment
Company assessmentDirect peers
- Caption Health: Caption Health developed AI software for ultrasound image acquisition guidance and interpretation (acquired by GE HealthCare in 2023). It is a direct peer in applying deep learning to ultrasound to enable non-specialist clinical use.
- Exo Imaging: Exo Imaging produces handheld ultrasound devices with embedded AI for imaging guidance and diagnostics. It competes directly with Kriba in combining AI-augmented point-of-care ultrasound with specialty clinical applications.
- DiA Imaging Analysis: DiA Imaging Analysis provides AI-powered ultrasound analysis software (LVivo) for cardiac and other applications, partnering with ultrasound OEMs. Like Kriba, DiA applies deep learning to ultrasound imaging to automate disease detection and clinical decision support.
- Butterfly Network: Butterfly Network manufactures portable, AI-enabled ultrasound devices (iQ3) used at point of care across multiple clinical specialties. It is a direct peer in combining handheld ultrasound hardware with AI-based diagnostic analysis, similar to Kriba's Neosonics platform.
Broad incumbents
- GE HealthCare: GE HealthCare is a global leader in medical imaging including ultrasound systems (Voluson, Vscan) with increasing AI integration. It is a broad incumbent that competes across all of Kriba's clinical verticals via established hospital relationships and full ultrasound portfolios.
- Siemens Healthineers: Siemens Healthineers manufactures ultrasound systems (ACUSON) and AI-driven imaging applications (AI-Rad Companion). It is a broad incumbent competitor and potential strategic acquirer for AI-ultrasound specialists.
- Philips: Philips is a major medical imaging incumbent with ultrasound systems (Affiniti, EPIQ) and AI-enabled clinical applications. It competes broadly in hospital imaging purchasing decisions and represents a potential strategic acquirer for Kriba.
- Samsung Medison: Samsung Medison develops ultrasound systems with AI-enabled features (S-Detect, HeartAssist) for OB/GYN, radiology, and point-of-care applications. It competes broadly in the AI-ultrasound market overlapping Kriba's clinical applications.
- Mindray: Mindray is a leading global ultrasound manufacturer with AI features across its product lines. It competes broadly in the hospital and point-of-care ultrasound market and could acquire niche AI-ultrasound specialists like Kriba.
Emerging players
- Ultromics: Ultromics applies AI to echocardiography for cardiac disease detection (e.g., heart failure, amyloid). It shares Kriba's model of using AI on ultrasound imagery to automate disease screening in a specialty clinical workflow.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
New Born Solutions social profiles
Digital presenceNew Born Solutions financial estimates
Financial estimateRevenue estimate
Valuation estimate
New Born Solutions leadership team
Management profileNumber of profiles
Profiles2 records
New Born Solutions funding detail
Funding detailFunding overview
Funding rounds3 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
New Born Solutions M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about New Born Solutions
What does New Born Solutions do?
New Born Solutions (operating as Kriba) develops Neosonics, a proprietary medical device platform that combines high-resolution ultrasound imaging with artificial intelligence and deep learning to enable non-invasive screening, diagnosis, and monitoring of infections in serous body fluids. The platform addresses three clinical applications: transfontanellar ultrasound-based meningitis screening for newborns and young infants, automated peritonitis detection and monitoring for patients on home peritoneal dialysis, and deep learning-aided uveitis screening for ophthalmology patients.
Is New Born Solutions a public or private company?
New Born Solutions is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was New Born Solutions founded?
New Born Solutions was founded in 2015. It employs 1 to 10 people.
Where is New Born Solutions based?
New Born Solutions is headquartered in Barcelona, Spain, in the Europe region.
How does New Born Solutions make money?
Two revenue lines are on record. Medical Device and Technology Licensing is the primary driver. The others are european Innovation Council Accelerator Funding.
Who are New Born Solutions's main competitors?
Direct peers on record are Caption Health, Exo Imaging, DiA Imaging Analysis and Butterfly Network. Broad incumbents are GE HealthCare, Siemens Healthineers, Philips, Samsung Medison and Mindray. Ultromics is listed as an emerging player.
Does New Born Solutions have an API?
No public API is recorded for New Born Solutions.
What industry is New Born Solutions in?
New Born Solutions's product category is Medical Imaging Devices. Its primary akta.pro industry code is HLAHABAD, Ultrasound & Echography Systems, with a secondary code of HDAAAEAH, Medical Imaging AI. Its NAICS code is 334510 and its SIC code is 3841.